Browse studies, page 756

Page 756 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.

• A Prospective, Double-blind, Sham-controlled, Randomized Clinical Trial to Assess the Safety and Efficacy of the Mi-Helper Device for Acute Treatment of Migraine in an At Home Setting ClinicalTrials.gov · COMPLETED, 2025
• Repeated Bilateral Greater Occipital Nerve Blockade in Chronic Migraine and Chronic Tension-Type Headache: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial ClinicalTrials.gov · COMPLETED, 2025
• Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain Sickness ClinicalTrials.gov · COMPLETED, 2024
• Comparison of the Efficacy of Unilateral and Bilateral Proximal Greater Occipital Nerve Pulsed Radiofrequency in the Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2026
• Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-finding Trial of Lu AG09222 for the Prevention of Migraine in Participants With Unsuccessful Prior Preventive Treatments ClinicalTrials.gov · COMPLETED, 2026
• Melatonin fOr CHronic bAck Pain (The MOCHA Trial): A Randomized, Double Blind, Placebo-controlled Trial ClinicalTrials.gov · COMPLETED, 2026
• Effects of Hemp-Derived Cannabinoids on Menopause Symptoms ClinicalTrials.gov · COMPLETED, 2025
• Synergistic Impact of Postural Correction Interventions and Sustained Natural Apophyseal Glides on Severity, Disability and Quality of Life in Patients With Migraine ClinicalTrials.gov · COMPLETED, 2025
• A Single Center, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Fremanezumab (675 mg Quarterly) in Female Patients Aged 18-45 With Menstrual Migraine ClinicalTrials.gov · COMPLETED, 2026
• Effects of Transcutaneous Electrical Nerve stimulatıon and Exercise Training on Pain and functionalıty in Women With Migraine ClinicalTrials.gov · COMPLETED, 2026
• Efficacy of Traditional Integrated Islamic Psychotherapy and Cognitive Behavioural Therapy for Migraine: A Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2026
• Impact of Promoting Physical Exercise on Migraine - a Video-based Randomized Clinical Trial ClinicalTrials.gov · COMPLETED, 2024
• A phase 1, open label, single dose, randomized, crossover study to evaluate the bioequivalence of TWO formulations of a cgrp receptor antagonist in healthy adult participants ClinicalTrials.gov · COMPLETED, 2026
• Personalised Process-based Psychological Intervention for Paediatric Headache Cases: An Idiographic Ecological Momentary Study With Weekly Feedback Provision ClinicalTrials.gov · COMPLETED, 2025
• Efficacy of Carotenoids on Blood Biomarkers Following A Collision Sport Athletes ClinicalTrials.gov · COMPLETED, 2024
• Evaluation of the Effectiveness of Virtual Reality-Based Vestibular Rehabilitation in Patients With Vestibular Migraine: A Randomized Controlled Trial ClinicalTrials.gov · COMPLETED, 2026
• Phase 2 Double-Blind, Randomized, Placebo Controlled, Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2025
• VIBRANT-VM: Vestibular Investigation of Bone-conducted Resonant Analysis of Time-constants in Patients With Vestibular Migraines ClinicalTrials.gov · COMPLETED, 2025
• The Effect of Cervical Stabilization Training and Vestibular Training on Cervical Region and Balance in Individuals With Migraine ClinicalTrials.gov · COMPLETED, 2025
• Effectiveness of Manual Lymphatic Drainage in the Physiotherapeutic Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2026
• Treatment Patterns, Medication Usage, Effectiveness, and Safety Among US Veterans Using the Remote Electrical Neuromodulation (REN) Wearable Device for Migraine Treatment ClinicalTrials.gov · COMPLETED, 2026
• The Effect of Treatment Onset Time on Acute Treatment Efficacy in Migraine Patients Using Remote Electrical Neuromodulation (REN) ClinicalTrials.gov · COMPLETED, 2025
• Exploring the Effect of the Transcendental Meditation® Technique on Migraine Frequency, Intensity, and Functionality: A Single-Arm Study ClinicalTrials.gov · COMPLETED, 2026
• Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients : Study on Head Pain Characteristic and MIDAS-Ina Score ClinicalTrials.gov · COMPLETED, 2025
• A Phase I, Randomized, Double-blind, Placebo-controlled, Single and Multiple Doses Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PRT-064040 Nasal Spray in Healthy Adult Subjects ClinicalTrials.gov · COMPLETED, 2025
• Foot Reflexology as an Adjunctive Therapy in Migraine Management: A Randomized Controlled Trial on Pain, Fatigue, and Quality of Life ClinicalTrials.gov · COMPLETED, 2025
• Clinical Outcomes of Sphenopalatine Ganglion Pulsed Radiofrequency in Refractory Craniofacial Pain Syndromes: A Prospective Clinical Study ClinicalTrials.gov · COMPLETED, 2026
• A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-severe Systemic Disease Activity ClinicalTrials.gov · COMPLETED, 2026
• Interventional, Randomized, Double-blind, Placebo-controlled Trial Investigating the Safety and Tolerability of Lu AG09222 When Coadministered With Ubrogepant in Participants With Migraine ClinicalTrials.gov · COMPLETED, 2025
• Development, Validity and Reliability Study of the Health Belief Model Scale Regarding Disability and Abilities in Vestibular Migraine Patients ClinicalTrials.gov · COMPLETED, 2026
• A Randomized Controlled Trial of a Transcutaneous Electrical Nerve Stimulation Device for the Acute Treatment of Migraine ClinicalTrials.gov · COMPLETED, 2025
• The Effect of Foot Reflexology on Pain, Disability, Anxiety, Kinesiophobia, and Postural Control in Women With Migraine ClinicalTrials.gov · COMPLETED, 2026
• Glutamate as a Therapeutic Substrate in Migraine International Journal of Molecular Sciences, 2025
• Migraine through puberty and menopausal transition—data from the population-based Norwegian Women and Health study (NOWAC) The Journal of Headache and Pain, 2025
• Migraine and functional neurological disorder (FND)—a review of comorbidity and potential overlap Brain Communications, 2025
• Effectiveness and tolerability of atogepant as preventive treatment in resistant individuals with chronic migraine: Six-month real-world evidence Cephalalgia, 2025
• Sex difference in TRPM3 channel functioning in nociceptive and vascular systems: an emerging target for migraine therapy in females? The Journal of Headache and Pain, 2025
• A 24-week prospective, multicenter, real-world study on eptinezumab’s effectiveness and safety in migraine prevention (EMBRACE II) Journal of Neurology, 2025
• Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days Cephalalgia, 2025
• Deciphering the mechanisms: Pathophysiology of migraine-related cognitive dysfunction Cephalalgia, 2025
• Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic Horizons Journal of Clinical Medicine, 2025
• An analysis of the burden of migraine and tension-type headache across the global, China, the United States, India and Japan Frontiers in Pain Research, 2025
• Impaired glymphatic function contributes to high-frequency attacks in patients with episodic migraine The Journal of Headache and Pain, 2025
• Mechanistic intersections between migraine and major depressive disorder The Journal of Headache and Pain, 2025
• The burden of migraine and predictions in the Asia–Pacific region, 1990–2021: a comparative analysis of China, South Korea, Japan, and Australia The Journal of Headache and Pain, 2025
• Migraine in men – differences in phenotype and treatment patterns: results from the Migraine in Poland cross-sectional national survey The Journal of Headache and Pain, 2025
• Migraine and increased cardiovascular disease risk: interaction with traditional risk factors and lifestyle factors The Journal of Headache and Pain, 2025
• The global and regional burden and trends of migraine from 1990 to 2021: Global Burden of Disease Study 2021 Frontiers in Neurology, 2025
• Serum GFAP and NfL levels in migraine: A registry for migraine (REFORM) study Cephalalgia, 2025
• Burden of migraine among Egyptian people: prevalence and comorbidities The Journal of Headache and Pain, 2025
• A Monoclonal Antibody to PACAP for Migraine Prevention New England Journal of Medicine, 2024
• Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: A call to action Cephalalgia, 2024
• Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine The Journal of Headache and Pain, 2024
• Effectiveness and tolerability of liraglutide as add-on treatment in patients with obesity and high-frequency or chronic migraine: A prospective pilot study Headache, 2025
• OnabotulinumtoxinA treatment for chronic migraine in pregnancy: An updated report of real-world headache and pregnancy outcomes over 14 years in Hull Cephalalgia, 2025
• Peripherally acting anti-CGRP monoclonal antibodies attenuate cortical resting-state connectivity in migraine patients Cephalalgia, 2025
• CGRP-Targeted Migraine Therapies in Patients With Vascular Risk Factors or Stroke: A Review Neurology, 2025
• Rizatriptan vs Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial JAMA Neurology, 2025
• CGRP and Migraine: Real World Insights and Future Therapeutic Directions Annual Review of Medicine, 2025
• Magnesium and Migraine Nutrients, 2025
• Serial systemic immune inflammation indices: markers of acute migraine events or indicators of persistent inflammatory status? The Journal of Headache and Pain, 2025
• Unveiling new insights into migraine risk stratification using machine learning models of adjustable risk factors The Journal of Headache and Pain, 2025
• Unmasking the relationship between CGRP and glutamate: from peripheral excitation to central sensitization in migraine The Journal of Headache and Pain, 2025
• The burden of migraine and tension-type headache in Asia from 1990 to 2021 The Journal of Headache and Pain, 2025
• Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment Pain Management, 2025
• Gepants: targeting the CGRP pathway for migraine relief Frontiers in Pharmacology, 2025
• Exploring vestibulocerebellum-vestibular nuclei-spinal trigeminal nucleus causals communication and TRPV2 ion channel in a mouse model of vestibular migraine The Journal of Headache and Pain, 2025
• Anxiety Disorders, Anxious Symptomology and Related Behaviors Associated With Migraine: A Narrative Review of Prevalence and Impact Current Pain and Headache Reports, 2025
• Application of machine learning in migraine classification: a call for study design standardization and global collaboration The Journal of Headache and Pain, 2025
• The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness survey BMC Public Health, 2025
• Trigeminal nerve microstructure is linked with neuroinflammation and brainstem activity in migraine Brain : a journal of neurology, 2025
• PACAP versus CGRP in migraine: From mouse models to clinical translation Cephalalgia, 2025
• The vessel-to-neuron trigeminovascular hypothesis of migraine pathogenesis – the ‘pro’ argument The Journal of Headache and Pain, 2025
• Cardiovascular risk and triptan usage among patients with migraine Headache, 2025
• The Current Role of Artificial Intelligence in the Field of Headache Disorders, with a Focus on Migraine: A Systemic Review Headache and Pain Research, 2025
• Digital phenotyping for migraine: A game-changer for research and management Cephalalgia, 2025
• Update on Neuromodulation for Migraine and Other Primary Headache Disorders: Recent Advances and New Indications Current Pain and Headache Reports, 2025
• The Role of Inflammation in Migraine Headaches: A Review FASEB bioAdvances, 2025
• Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study Journal of Neurology, 2025
• Early treatment in migraine – A call to shift prevention from attacks to disease progression: A position statement from the International Headache Society Cephalalgia, 2025
• IDO1 modulates pain sensitivity and comorbid anxiety in chronic migraine through microglial activation and synaptic pruning Journal of Neuroinflammation, 2025
• The role and interaction of hypothalamic-related neurotransmitters in migraine The Journal of Headache and Pain, 2025
• Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine JAMA Neurology, 2025
• Revisiting substance P in migraine: a methodological approach inspired by anti-CGRP and anti-PACAP success The Journal of Headache and Pain, 2025
• Menopause, Perimenopause, and Migraine: Understanding the Intersections and Implications for Treatment Neurological Therapeutics, 2025
• Current Trends in Pediatric Migraine: Clinical Insights and Therapeutic Strategies Brain Science, 2025
• The Global Burden of Migraine: A 30-Year Trend Review and Future Projections by Age, Sex, Country, and Region Pain and Therapy, 2024
• Metabolic Dysfunction and Dietary Interventions in Migraine Management: The Role of Insulin Resistance and Neuroinflammation—A Narrative and Scoping Review Brain Science, 2025
• Effectiveness and tolerability of rimegepant in the acute treatment of migraine: a real-world, prospective, multicentric study (GAINER study) The Journal of Headache and Pain, 2025
• GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures The Journal of Headache and Pain, 2025
• Calcitonin gene-related peptide-targeted therapy in migraine: current role and future perspectives The Lancet, 2025
• Setting higher standards for migraine prevention: A position statement of the International Headache Society Cephalalgia, 2025
• The effectiveness of clinical hypnosis on migraine headache symptoms and pain perception The American journal of clinical hypnosis, 2026
• Cognitive functions in patients with vestibular migraine: Is there any difference from patients with migraine headaches only? Journal of vestibular research : equilibrium & orientation, 2026
• Multimodal 7T MRI reveals subcortical structural, functional, iron accumulation, and glymphatic abnormalities in chronic migraine Cephalalgia : an international journal of headache, 2026
• Long-term safety of CGRP pathway inhibitors in migraine patients with prior cerebrovascular or cardiovascular disease Journal of neurology, 2026
• Time from Migraine Onset to Surgery Predicts Postoperative Headache Frequency: A Retrospective Cohort Study Plastic and reconstructive surgery, 2026
• Impact of Dietary Patterns on Migraine Management: Mechanisms of Action and Recent Literature Insights Brain and behavior, 2025
• Inflammatory Cytokine Signatures Are Associated With Disease Burden and Comorbidity of Episodic Migraine and Endometriosis Neurology(R) neuroimmunology & neuroinflammation, 2025
• The role of hypertension in the relationship between leisure screen time, physical activity and migraine: a 2-sample Mendelian randomization study The journal of headache and pain, 2024